EASL Recommendations on Treatment of Hepatitis C 2015

In 2015, EASL released updated recommendations on treatment of hepatitis C. These recommendations are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic hepatitis C infections.

World Hepatitis Summit

From 2-4 September, the World Hepatitis Summit was held in order to upscale the world’s response to hepatitis and to address the need for a global forum to examine public health approaches to the disease. The Summit is a joint World Health Organization (WHO) and World Hepatitis Alliance (WHA).

The Summit resulted in the Glasgow Declaration on Hepatitis.

July 28^th World Hepatitis Day

The VHPB endorses the World hepatitis day on 28 July. Therefor we would like to invite you to visit the website of the related organisation who are active today in raising awareness about viral hepatitis, and  urge policy-makers, health workers and the public to act now to prevent infection and death from hepatitis.

Partners sign call to action on hepatitis

Participants of the first global partners' meeting on hepatitis convened by WHO in March 2014 agree on a historic "Call to action to scale up global hepaitis response". The "call to action" presses the global community for immediate and concerted action to increase access to prevention, diagnosis and treatment of viral hepatitis. 

WHO issues its first hepatitis C treatment guidelines

These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention and transmission of bloodborne viruses, including HCV. They are intended for policy-malers, government officials and other working in low- and middleincome countries who are developing programmes for the screening, care and treatment of persons with HCV infection.

World Health Assembly adopted resolution on hepatitis

On May 22 2014, the World Health Assembly adopted a resolution to improve the prevention, diagnosis and treatment of viral hepatitis.

EASL Recommendations on Treatment of Hepatitis C 2014

In April 2014, EASL released updated recommendations on treatment of hepatitis C. These recommendations are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the optimal management of patients with acute and chronic hepatitis C infections.

WHO launched their new global policy report on the prevention and control of viral hepatitis.

WHO global policy report on the prevention and control of viral hepatitis in WHO Member States, is a report based on findings of a survey performed by WHO in collaboration with the World hepatitis alliance, mid-2012 and responded by 126 countries. The survey asked Member States to provide information relating to the four axes of the WHO strategy. In particular, Member States were asked whether key prevention and control activities are being conducted.